Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nopan as add-on to Antidepressants for Depression and Suicidality
NCT01046851Phase 3Unknown
- Start
- Sep 2008
- Primary completion
- Dec 2011
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Nopan in Suicidality and major depressive disorder (MDD). Primary endpoint: Beck Scale for Suicide Ideation at 4 weeks. Status: unknown.
02
Drugs
Nopan
03
Conditions
Suicidalitymajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01046851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01046851.